1026556

Cytovance Biologics Inc. — FEI 3006341547

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 20, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Oklahoma City, OK (United States)